Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability

被引：0
|
作者：
Andrew Dickman
Matthew Bickerstaff
Richard Jackson
Jennifer Schneider
Stephen Mason
John Ellershaw
机构：
[1] Cancer Research Centre,Marie Curie Palliative Care Institute Liverpool
[2] University of Liverpool,Cancer Research UK Liverpool Cancer Trials Unit
[3] University of Newcastle,School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine
来源：
BMC Palliative Care | / 16卷
关键词：
Palliative medicine; Drug combinations; Infusions; Subcutaneous; Delphi technique; Surveys; Questionnaires; Patient safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] ANALYSIS OF A COHORT OF PEDIATRIC PATIENTS TREATED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    Bonfanti, R.
    Rigamonti, A.
    Frontino, G.
    Favalli, R.
    Bonura, C.
    Battaglino, R.
    Rubino, C.
    Bova, B.
    Meschi, F.
    Chiumello, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A57 - A58
  • [32] AN ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) PUMP USAGE IN FLORIDA
    WILLIAMS, PE
    DEEB, LC
    DIABETES, 1983, 32 : A48 - A48
  • [33] Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units
    Kanji, Salmaan
    Lam, Jason
    Johanson, Christel
    Singh, Avinder
    Goddard, Rob
    Fairbairn, Jennifer
    Lloyd, Tammy
    Monsour, Danny
    Kakal, Juzer
    CRITICAL CARE MEDICINE, 2010, 38 (09) : 1890 - 1898
  • [34] A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump
    Raskin, P
    Holcombe, JH
    Tamborlane, WV
    Malone, JI
    Strowig, S
    Ahern, JA
    Lavent, F
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (06) : 295 - 300
  • [35] CLINICAL AND COMPATIBILITY STUDIES OF 5-FLUOROURACIL (5-FU) AND HEPARIN (HN) ADMINISTERED BY CONTINUOUS IV INFUSION
    COUGHENOUR, M
    SLAVIK, M
    FABIAN, C
    BROWN, N
    CHENG, CC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 191 - 191
  • [36] ANALYSIS OF A STRUCTURED EDUCATIONAL PROGRAM FOR CANDIDATES FOR THERAPY WITH SUBCUTANEOUS CONTINUOUS INSULIN INFUSION
    Pazos-Couselo, M.
    Garcia-Lopez, J. M.
    Andujar-Plata, P.
    Caamano-Lois, N.
    Sigueiro-Paulos, S.
    Izquierdo, V.
    Gonzalez-Rodriguez, M.
    Rodriguez-Gonzalez, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A171 - A171
  • [37] Adequate plasma drug concentrations suggest that amoxicillin can be administered by continuous infusion using elastomeric pumps
    Arensdorff, Lyne
    Boillat-Blanco, Noemie
    Decosterd, Laurent
    Buclin, Thierry
    de Valliere, Serge
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (09) : 2613 - 2615
  • [38] Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes
    Bode, BW
    Strange, P
    DIABETES CARE, 2001, 24 (01) : 69 - 72
  • [39] Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study
    Bode, Bruce
    Garg, Satish
    Norwood, Paul
    Morales, Cristobal
    Hardy, Thomas
    Liu, Rong
    Ignaut, Debra
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (01) : 41 - 50
  • [40] Compatibility and safety of faster-acting insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes
    Zijlstra, Eric
    Demissie, Marek
    Graungaard, Tina
    Heise, Tim
    Nosek, Leszek
    Bode, Bruce W.
    CLINICAL ENDOCRINOLOGY, 2017, 86 : 46 - 46
12345